Completed × NETWORK × Leukemia, Lymphocytic, Chronic, B-Cell × Clear all HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide
Phase 2 Completed
80 enrolled 56 charts
CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7
Phase 2 Completed
52 enrolled
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
Completed
174 enrolled
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
Phase 2 Completed
127 enrolled 20 charts
Buparlisib in Patients With Relapsed and Refractory Chronic Lymphocytic Leukemia
Phase 2 Completed
14 enrolled 9 charts
Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma
Phase 1 Completed
35 enrolled
A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia
Phase 2 Completed
7 enrolled
Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL
Phase 2 Completed
102 enrolled 11 charts
Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia
Phase 2 Completed
Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia
Phase 2 Completed
Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Completed
1,873 enrolled
Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
Phase 3 Completed
280 enrolled
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
Phase NA Completed
434 enrolled
Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma
Phase 2 Completed
77 enrolled
Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia
Phase 2 Completed
128 enrolled
Treatment for Chronic Pain in Patients With Advanced Cancer
Phase 3 Completed
87 enrolled
17p-CLL
Completed
41 enrolled
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
Completed
2,545 enrolled
Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant
Completed
304 enrolled
Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer
Phase 1 Completed
29 enrolled
PLRG4
Phase 3 Completed
250 enrolled
Biomarkers in Samples From Patients With Chronic Lymphocytic Leukemia Treated on Clinical Trial ECOG-2997
Completed
225 enrolled
Biomarkers in DNA Samples From Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine-Based Therapy
Completed
225 enrolled
Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
Phase 3 Completed
472 enrolled
S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Phase 1 Completed
66 enrolled
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Phase 1 Completed
49 enrolled
SWOG-9245 Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Completed
32 enrolled
SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant
Phase 2 Completed
20 enrolled
Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count
Phase 3 Completed
859 enrolled
Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients
Phase 3 Completed
115 enrolled
Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant
Phase 2 Completed
171 enrolled
Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma
Phase 2 Completed
96 enrolled
Flu-Mel
Phase 2 Completed
38 enrolled